SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cypress Bioscience Inc – ‘10-K’ for 12/31/03 – EX-32.1

On:  Monday, 3/29/04, at 6:01am ET   ·   For:  12/31/03   ·   Accession #:  1047469-4-9648   ·   File #:  0-12943

Previous ‘10-K’:  ‘10-K/A’ on 7/17/03 for 12/31/02   ·   Next:  ‘10-K’ on 3/16/05 for 12/31/04   ·   Latest:  ‘10-K’ on 3/31/10 for 12/31/09

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/29/04  Cypress Bioscience Inc            10-K       12/31/03   16:1.4M                                   Merrill Corp/New/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    594K 
 2: EX-10.22    Material Contract                                   HTML     52K 
 3: EX-10.23    Material Contract                                   HTML    212K 
 4: EX-10.24    Material Contract                                   HTML     50K 
 5: EX-10.25    Material Contract                                   HTML    150K 
 6: EX-10.26    Material Contract                                   HTML    212K 
 7: EX-10.27    Material Contract                                   HTML     18K 
 8: EX-10.28    Material Contract                                   HTML     76K 
 9: EX-10.29    Material Contract                                   HTML     37K 
10: EX-10.30    Material Contract                                   HTML     37K 
11: EX-10.31    Material Contract                                   HTML     38K 
12: EX-21.1     Subsidiaries of the Registrant                      HTML      8K 
13: EX-23.1     Consent of Experts or Counsel                       HTML     11K 
14: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)  HTML     14K 
15: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)  HTML     14K 
16: EX-32.1     Certification per Sarbanes-Oxley Act (Section 906)  HTML     11K 


EX-32.1   —   Certification per Sarbanes-Oxley Act (Section 906)
Exhibit Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Exhibit 32.1
"Certification Pursuant to Section 906
"QuickLinks

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




QuickLinks -- Click here to rapidly navigate through this document


Exhibit 32.1


CERTIFICATION PURSUANT TO SECTION 906

        I, Jay D. Kranzler, the Chief Executive Officer of Cypress Bioscience, Inc. (the "Company"), and I, Sabrina Martucci Johnson, the Chief Financial Officer of the Company, each hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:


Dated:    March 29, 2004

 

 

/s/ JAY D. KRANZLER

Chief Executive Officer

 

/s/ SABRINA MARTUCCI JOHNSON

Chief Financial Officer



QuickLinks

CERTIFICATION PURSUANT TO SECTION 906

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/29/043,  4,  424B5,  8-K
For Period End:12/31/03
 List all Filings 
Top
Filing Submission 0001047469-04-009648   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 5:03:20.1pm ET